Pharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in mice.
about
In Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide Nanoparticles.MicroRNA-Based Therapy in Animal Models of Selected Gastrointestinal CancersHyperthermia using nanoparticles--Promises and pitfalls.Polyethylene glycol-coated graphene oxide attenuates antigen-specific IgE production and enhanced antigen-induced T-cell reactivity in ovalbumin-sensitized BALB/c miceMagnetic Properties of Polyvinyl Alcohol and Doxorubicine Loaded Iron Oxide Nanoparticles for Anticancer Drug Delivery ApplicationsSuperparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.Preparation, Optimization and Toxicity Evaluation of (SPION-PLGA) ±PEG Nanoparticles Loaded with Gemcitabine as a Multifunctional Nanoparticle for Therapeutic and Diagnostic Applications.Characterization of Free and Porous Silicon-Encapsulated Superparamagnetic Iron Oxide Nanoparticles as Platforms for the Development of Theranostic Vaccines.Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.Altering iron oxide nanoparticle surface properties induce cortical neuron cytotoxicity.Preclinical evaluation of recombinant human IFNα2b-containing magnetoliposomes for treating hepatocellular carcinoma.In vivo screening of hepatocellular carcinoma using AC susceptibility of anti-alpha fetoprotein-activated magnetic nanoparticles.A noninvasive method to determine the fate of Fe(3)O(4) nanoparticles following intravenous injection using scanning SQUID biosusceptometry.The changes of T lymphocytes and cytokines in ICR mice fed with Fe3O4 magnetic nanoparticles.A single exposure to iron oxide nanoparticles attenuates antigen-specific antibody production and T-cell reactivity in ovalbumin-sensitized BALB/c mice.Influence of synthetic superparamagnetic iron oxide on dendritic cells.A role of cellular glutathione in the differential effects of iron oxide nanoparticles on antigen-specific T cell cytokine expressionBiocompatibility of Fe₃O₄@Au composite magnetic nanoparticles in vitro and in vivo.Effects of PVA coated nanoparticles on human immune cellsEfficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.Ultrasmall cationic superparamagnetic iron oxide nanoparticles as nontoxic and efficient MRI contrast agent and magnetic-targeting tool.Co-encapsulation of magnetic Fe3O4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery.Iron oxide nanoparticles suppressed T helper 1 cell-mediated immunity in a murine model of delayed-type hypersensitivity.Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles.Accumulation and Toxicity of Superparamagnetic Iron Oxide Nanoparticles in Cells and Experimental Animals.Iron administration before stem cell harvest enables MR imaging tracking after transplantation.Biodistribution of newly synthesized PHEA-based polymer-coated SPION in Sprague Dawley rats as magnetic resonance contrast agentCombination of gemcitabine-containing magnetoliposome and oxaliplatin-containing magnetoliposome in breast cancer treatment: A possible mechanism with potential for clinical application.Apoptosis selectively induced in BEL-7402 cells by folic acid-modified magnetic nanoparticles combined with 100 Hz magnetic fieldLayered double hydroxide nanocomposite for drug delivery systems; bio-distribution, toxicity and drug activity enhancement.Magnetic field enhanced convective diffusion of iron oxide nanoparticles in an osmotically disrupted cell culture model of the blood-brain barrier.New perspectives in nanotherapeutics for chronic respiratory diseases.Biomarkers of oxidative stress for in vivo assessment of toxicological effects of iron oxide nanoparticles.Interaction of cancer cells with magnetic nanoparticles modified by methacrylamido-folic acid.toxicity evaluation of silica-coated iron oxide nanoparticles in human SHSY5Y neuronal cellsCombined toxicity of FeO nanoparticles and cadmium chloride in miceLiposomes Loaded with Cisplatin and Magnetic Nanoparticles: Physicochemical Characterization, Pharmacokinetics, and In-Vitro Efficacy
P2860
Q26779017-E244B431-8290-4B27-AEAD-5EA9E2887034Q28076754-FC04CB5D-5EF2-442F-B3FA-C2A163B6E14AQ28384618-BA647F90-410B-4DEE-84E2-8AA0B9BDA5D9Q28394256-6D75FC44-7A22-44B9-9F6F-2DB19D163E1DQ28552162-AB18CCB5-38AB-450F-88E6-6E370F39EEC6Q30465367-00502EA6-DBC0-4558-AC32-20D102F2039CQ33652198-AB08C8B4-D37F-4C82-8CF8-71F70F67CBF9Q33752929-62CE0A7A-A5CB-42A1-A9F0-9AD9B4604AC2Q33807175-ACBC2913-9DC9-46EA-B481-2D4AC7ABCC54Q34280319-62FE51DB-B377-4C71-A04A-06F4F107D7F1Q34285853-1F6E6D7C-00B6-4340-82F3-3621DD18F453Q34442056-D8252BCB-1FE0-4E9B-B2E3-CB4BD488394DQ34477355-487451C5-0853-420B-9F4E-958309C052DBQ35023306-6C79DBC5-DE6A-4195-A1F6-EEF7A3FFA5C7Q35090480-72C49701-BF3C-494A-BD36-59819D7BDBB6Q35254464-7CF8BC56-4F67-4963-A165-A23B82D8549CQ35556947-09DD988E-379B-4319-B7EC-FDF726826F45Q35574688-9051628F-4F3D-41C1-8506-C4ED082164CDQ35605942-4C264683-52A6-4512-B346-7179C88C4AF0Q35672973-17E64B9D-E4D2-4379-A412-18F49F3CB065Q35914929-37158435-19A5-4407-A05F-58219E08A1A5Q35972543-09D391D8-8B6F-47CF-96D5-D1D9B7AAA1EEQ36027152-D2141426-B5D6-4E8D-979E-488E0693C106Q36088821-895AEF10-5EFB-4906-A90F-070BA40392F6Q36108983-6F4DE318-4798-4B15-B655-7005094C61BBQ37193042-3E58C303-4462-4FB9-91EE-5AFCA8CFF67AQ37278614-F2F651C8-F256-41C9-A598-2357D81A8B0CQ37536696-6923FD36-AF37-4385-B074-CA80588D11EDQ37729751-4F28C34B-4830-4B89-9B1D-AC9470E8FDB5Q38245232-ACB2FDF4-567F-44A7-ADCC-E6277CA372F4Q38975707-5472E19A-5961-4F1F-83B7-A6D84713A094Q40039105-A6177DA5-2859-4DDC-8B50-51FB298D32EEQ41457062-63E40C8C-3DF6-43FC-87E4-12B328988E3DQ41895191-812ED1F0-9C97-4440-BA49-CF67094EDD08Q57377094-A06B49F1-CC32-4D09-AFCD-2444D7B16CF0Q57377338-B6CB8F00-45FA-4ED5-88BD-28AB594FE5E5Q58691838-2519CE60-93FC-4862-B2EF-200B78C6C94C
P2860
Pharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pharmacokinetic parameters and tissue distribution of magnetic Fe
@nl
Pharmacokinetic parameters and ...... (3)O(4) nanoparticles in mice.
@ast
Pharmacokinetic parameters and ...... (3)O(4) nanoparticles in mice.
@en
type
label
Pharmacokinetic parameters and tissue distribution of magnetic Fe
@nl
Pharmacokinetic parameters and ...... (3)O(4) nanoparticles in mice.
@ast
Pharmacokinetic parameters and ...... (3)O(4) nanoparticles in mice.
@en
prefLabel
Pharmacokinetic parameters and tissue distribution of magnetic Fe
@nl
Pharmacokinetic parameters and ...... (3)O(4) nanoparticles in mice.
@ast
Pharmacokinetic parameters and ...... (3)O(4) nanoparticles in mice.
@en
P2093
P2860
P356
P1476
Pharmacokinetic parameters and ...... (3)O(4) nanoparticles in mice.
@en
P2093
Baoan Chen
Jiahua Ding
Jian Cheng
Xiaomao Li
Xue Mei Wang
P2860
P304
P356
10.2147/IJN.S13662
P407
P577
2010-10-21T00:00:00Z